Global IBS-C Drug Market Insights, Forecast to 2025

Global IBS-C Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 IBS-C Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global IBS-C Drug Market Size Growth Rate by Product
1.4.2 Linaclotide
1.4.3 Lubiprostone
1.4.4 Osmotic Laxatives
1.4.5 Stimulant Laxatives
1.4.6 Other
1.5 Market by End User
1.5.1 Global IBS-C Drug Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global IBS-C Drug Market Size
2.1.1 Global IBS-C Drug Revenue 2014-2025
2.1.2 Global IBS-C Drug Sales 2014-2025
2.2 IBS-C Drug Growth Rate by Regions
2.2.1 Global IBS-C Drug Sales by Regions
2.2.2 Global IBS-C Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 IBS-C Drug Sales by Manufacturers
3.1.1 IBS-C Drug Sales by Manufacturers
3.1.2 IBS-C Drug Sales Market Share by Manufacturers
3.1.3 Global IBS-C Drug Market Concentration Ratio (CR5 and HHI)
3.2 IBS-C Drug Revenue by Manufacturers
3.2.1 IBS-C Drug Revenue by Manufacturers (2014-2019)
3.2.2 IBS-C Drug Revenue Share by Manufacturers (2014-2019)
3.3 IBS-C Drug Price by Manufacturers
3.4 IBS-C Drug Manufacturing Base Distribution, Product Types
3.4.1 IBS-C Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IBS-C Drug Product Type
3.4.3 Date of International Manufacturers Enter into IBS-C Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global IBS-C Drug Sales by Product
4.2 Global IBS-C Drug Revenue by Product
4.3 IBS-C Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global IBS-C Drug Breakdown Data by End User
6 North America
6.1 North America IBS-C Drug by Countries
6.1.1 North America IBS-C Drug Sales by Countries
6.1.2 North America IBS-C Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America IBS-C Drug by Product
6.3 North America IBS-C Drug by End User
7 Europe
7.1 Europe IBS-C Drug by Countries
7.1.1 Europe IBS-C Drug Sales by Countries
7.1.2 Europe IBS-C Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe IBS-C Drug by Product
7.3 Europe IBS-C Drug by End User
8 Asia Pacific
8.1 Asia Pacific IBS-C Drug by Countries
8.1.1 Asia Pacific IBS-C Drug Sales by Countries
8.1.2 Asia Pacific IBS-C Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific IBS-C Drug by Product
8.3 Asia Pacific IBS-C Drug by End User
9 Central & South America
9.1 Central & South America IBS-C Drug by Countries
9.1.1 Central & South America IBS-C Drug Sales by Countries
9.1.2 Central & South America IBS-C Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America IBS-C Drug by Product
9.3 Central & South America IBS-C Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa IBS-C Drug by Countries
10.1.1 Middle East and Africa IBS-C Drug Sales by Countries
10.1.2 Middle East and Africa IBS-C Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa IBS-C Drug by Product
10.3 Middle East and Africa IBS-C Drug by End User
11 Company Profiles
11.1 Catalent Pharmaceuticals Solutions
11.1.1 Catalent Pharmaceuticals Solutions Company Details
11.1.2 Company Business Overview
11.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Catalent Pharmaceuticals Solutions IBS-C Drug Products Offered
11.1.5 Catalent Pharmaceuticals Solutions Recent Development
11.2 Nestle
11.2.1 Nestle Company Details
11.2.2 Company Business Overview
11.2.3 Nestle IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Nestle IBS-C Drug Products Offered
11.2.5 Nestle Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Abbott Laboratories IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abbott Laboratories IBS-C Drug Products Offered
11.3.5 Abbott Laboratories Recent Development
11.4 Synergy Pharmaceuticals
11.4.1 Synergy Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Synergy Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Synergy Pharmaceuticals IBS-C Drug Products Offered
11.4.5 Synergy Pharmaceuticals Recent Development
11.5 Sucampo Pharmaceuticals
11.5.1 Sucampo Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sucampo Pharmaceuticals IBS-C Drug Products Offered
11.5.5 Sucampo Pharmaceuticals Recent Development
11.6 Novartis Pharma
11.6.1 Novartis Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Pharma IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Pharma IBS-C Drug Products Offered
11.6.5 Novartis Pharma Recent Development
11.7 Astellas Pharmaceuticals
11.7.1 Astellas Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Astellas Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Astellas Pharmaceuticals IBS-C Drug Products Offered
11.7.5 Astellas Pharmaceuticals Recent Development
11.8 Ardelyx
11.8.1 Ardelyx Company Details
11.8.2 Company Business Overview
11.8.3 Ardelyx IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Ardelyx IBS-C Drug Products Offered
11.8.5 Ardelyx Recent Development
11.9 Synthetic Biologics
11.9.1 Synthetic Biologics Company Details
11.9.2 Company Business Overview
11.9.3 Synthetic Biologics IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Synthetic Biologics IBS-C Drug Products Offered
11.9.5 Synthetic Biologics Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Company Business Overview
11.10.3 Teva Pharmaceutical Industries IBS-C Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Teva Pharmaceutical Industries IBS-C Drug Products Offered
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Bama-Geve
11.12 Ferring BV
11.13 Ironwood Pharmaceuticals
11.14 Salix Pharmaceuticals
11.15 Norgine
11.16 Prometheus Laboratories
11.17 Actavis Nordic
11.18 Albireo Pharma
11.19 Yuhan Corp
11.20 Astrazeneca
11.21 The Menarini Group
11.22 Ono Pharmaceutical
12 Future Forecast
12.1 IBS-C Drug Market Forecast by Regions
12.1.1 Global IBS-C Drug Sales Forecast by Regions 2019-2025
12.1.2 Global IBS-C Drug Revenue Forecast by Regions 2019-2025
12.2 IBS-C Drug Market Forecast by Product
12.2.1 Global IBS-C Drug Sales Forecast by Product 2019-2025
12.2.2 Global IBS-C Drug Revenue Forecast by Product 2019-2025
12.3 IBS-C Drug Market Forecast by End User
12.4 North America IBS-C Drug Forecast
12.5 Europe IBS-C Drug Forecast
12.6 Asia Pacific IBS-C Drug Forecast
12.7 Central & South America IBS-C Drug Forecast
12.8 Middle East and Africa IBS-C Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IBS-C Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure IBS-C Drug Product Picture
Table IBS-C Drug Market Segments
Table Key Manufacturers IBS-C Drug Covered
Table Global IBS-C Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global IBS-C Drug Sales Market Share by Product 2014-2025
Figure Linaclotide Product Picture
Table Major Manufacturers of Linaclotide
Figure Lubiprostone Product Picture
Table Major Manufacturers of Lubiprostone
Figure Osmotic Laxatives Product Picture
Table Major Manufacturers of Osmotic Laxatives
Figure Stimulant Laxatives Product Picture
Table Major Manufacturers of Stimulant Laxatives
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global IBS-C Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure IBS-C Drug Report Years Considered
Figure Global IBS-C Drug Market Size 2014-2025 (Million US$)
Figure Global IBS-C Drug Sales 2014-2025 (K Units)
Table Global IBS-C Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global IBS-C Drug Sales by Regions 2014-2019 (K Units)
Table Global IBS-C Drug Sales Market Share by Regions 2014-2019
Figure Global IBS-C Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global IBS-C Drug Sales Market Share by Regions
Table Global IBS-C Drug Revenue by Regions 2014-2019 (Million US$)
Table Global IBS-C Drug Revenue Market Share by Regions 2014-2019
Figure Global IBS-C Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global IBS-C Drug Revenue Market Share by Regions
Table Global IBS-C Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global IBS-C Drug Sales Share by Manufacturers (2014-2019)
Figure Global IBS-C Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table IBS-C Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table IBS-C Drug Revenue Share by Manufacturers (2014-2019)
Figure IBS-C Drug Value Share by Manufacturers in 2018
Table Key Manufacturers IBS-C Drug Price (2014-2019) (USD/Unit)
Table IBS-C Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers IBS-C Drug Product Type
Table Date of International Manufacturers Enter into IBS-C Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global IBS-C Drug Sales by Product (2014-2019) (K Units)
Table Global IBS-C Drug Sales Share by Product (2014-2019)
Figure Global IBS-C Drug Sales Market Share by Product (2014-2019)
Figure Global IBS-C Drug Sales Market Share by Product in 2018
Table Global IBS-C Drug Revenue by Product (2014-2019) (Million US$)
Table Global IBS-C Drug Revenue Share by Product (2014-2019)
Figure Global IBS-C Drug Revenue Market Share by Product (2014-2019)
Figure Global IBS-C Drug Revenue Market Share by Product in 2018
Table IBS-C Drug Price by Product 2014-2019 (USD/Unit)
Table Global IBS-C Drug Sales by End User (2014-2019) (K Units)
Table Global IBS-C Drug Sales Share by End User (2014-2019)
Figure Global Sales IBS-C Drug Market Share by End User (2014-2019)
Figure Global Sales IBS-C Drug Market Share by End User in 2018
Figure North America IBS-C Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America IBS-C Drug Sales by Countries (2014-2019) (K Units)
Table North America IBS-C Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America IBS-C Drug Sales Market Share by Countries
Table North America IBS-C Drug Revenue by Countries (2014-2019) (Million US$)
Table North America IBS-C Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America IBS-C Drug Revenue Market Share by Countries
Figure United States IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States IBS-C Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America IBS-C Drug Sales by Product (2014-2019) (K Units)
Table North America IBS-C Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America IBS-C Drug Market Share by Product
Table North America IBS-C Drug Sales by End User (2014-2019) (K Units)
Table North America IBS-C Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America IBS-C Drug Market Share by End User
Figure Europe IBS-C Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe IBS-C Drug Sales by Countries (2014-2019) (K Units)
Table Europe IBS-C Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe IBS-C Drug Sales Market Share by Countries
Table Europe IBS-C Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe IBS-C Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe IBS-C Drug Revenue Market Share by Countries
Figure Germany IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure France IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe IBS-C Drug Sales by Product (2014-2019) (K Units)
Table Europe IBS-C Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe IBS-C Drug Market Share by Product
Table Europe IBS-C Drug Sales by End User (2014-2019) (K Units)
Table Europe IBS-C Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe IBS-C Drug Market Share by End User
Figure Asia Pacific IBS-C Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific IBS-C Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific IBS-C Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific IBS-C Drug Sales Market Share by Countries
Table Asia Pacific IBS-C Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific IBS-C Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific IBS-C Drug Revenue Market Share by Countries
Figure China IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure China IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure India IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific IBS-C Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific IBS-C Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific IBS-C Drug Market Share by Product
Table Asia Pacific IBS-C Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific IBS-C Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific IBS-C Drug Market Share by End User
Figure Central & South America IBS-C Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America IBS-C Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America IBS-C Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America IBS-C Drug Sales Market Share by Countries
Table Central & South America IBS-C Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America IBS-C Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America IBS-C Drug Revenue Market Share by Countries
Figure Brazil IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America IBS-C Drug Sales by Product (2014-2019) (K Units)
Table Central & South America IBS-C Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America IBS-C Drug Market Share by Product
Table Central & South America IBS-C Drug Sales by End User (2014-2019) (K Units)
Table Central & South America IBS-C Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America IBS-C Drug Market Share by End User
Figure Middle East and Africa IBS-C Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa IBS-C Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa IBS-C Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa IBS-C Drug Sales Market Share by Countries
Table Middle East and Africa IBS-C Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa IBS-C Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa IBS-C Drug Revenue Market Share by Countries
Figure GCC Countries IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa IBS-C Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa IBS-C Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa IBS-C Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa IBS-C Drug Market Share by Product
Table Middle East and Africa IBS-C Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa IBS-C Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa IBS-C Drug Market Share by End User
Table Catalent Pharmaceuticals Solutions Company Details
Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Catalent Pharmaceuticals Solutions Recent Development
Table Nestle Company Details
Table Nestle IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nestle Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Synergy Pharmaceuticals Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sucampo Pharmaceuticals Recent Development
Table Novartis Pharma Company Details
Table Novartis Pharma IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Pharma Recent Development
Table Astellas Pharmaceuticals Company Details
Table Astellas Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharmaceuticals Recent Development
Table Ardelyx Company Details
Table Ardelyx IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ardelyx Recent Development
Table Synthetic Biologics Company Details
Table Synthetic Biologics IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Synthetic Biologics Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Bama-Geve Company Details
Table Ferring BV Company Details
Table Ironwood Pharmaceuticals Company Details
Table Salix Pharmaceuticals Company Details
Table Norgine Company Details
Table Prometheus Laboratories Company Details
Table Actavis Nordic Company Details
Table Albireo Pharma Company Details
Table Yuhan Corp Company Details
Table Astrazeneca Company Details
Table The Menarini Group Company Details
Table Ono Pharmaceutical Company Details
Table Global IBS-C Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global IBS-C Drug Sales Market Share Forecast by Regions 2019-2025
Table Global IBS-C Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global IBS-C Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global IBS-C Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global IBS-C Drug Sales Market Share Forecast by Product 2019-2025
Table Global IBS-C Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global IBS-C Drug Revenue Market Share Forecast by Product 2019-2025
Table Global IBS-C Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global IBS-C Drug Sales Market Share Forecast by End User 2019-2025
Figure North America IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table IBS-C Drug Value Chain
Table IBS-C Drug Customers List
Table IBS-C Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs